Affordable Access

Publisher Website

Comparative biochemical and immunological studies on gamma-glutamyltransferases from human kidney and renal cell carcinoma applying monoclonal antibodies

Authors
Journal
Clinica Chimica Acta
0009-8981
Publisher
Elsevier
Publication Date
Volume
191
Issue
3
Identifiers
DOI: 10.1016/0009-8981(90)90020-s
Keywords
  • Gamma-Glutamyltransferase (Ec 2.3.2.2)
  • Monoclonal Antibody
  • Renal Cell Carcinoma
  • Human Kidney
  • Isoenzyme
Disciplines
  • Biology
  • Chemistry
  • Design

Abstract

Abstract We have purified gamma-glutamyltransferases (GGT) from human kidneys and renal cell carcinomas, and fractionated them according to different lectin-binding properties of the isoenzymes. Native polyacrylamide gel electrophoresis and isoelectric focusing revealed different GGT-bands (even after desialylation) not only among kidney and renal carcinoma, but also among Con A-affine tumor fractions separated by ion-exchange chromatography. M r of native GGTs were between 106 to 161 kDa, the p I ranged from pH 3 to 4 (pH 5 to 6 after desialylation). Monoclonal antibodies to GGT were produced. One of these, of IgG 1 class and designed 138H11, recognizes human kidney GGT and, in addition, GGT from renal cell carcinomas and liver carcinomas. The specificity of mAb 138H11 for GGT was confirmed by Western blotting, by immunohistochemistry and by immunoprecipitation. The potential usefulness of mAb 138H11 in monitoring renal cancer patients and in identification of renal cancer metastases is currently being studied.

There are no comments yet on this publication. Be the first to share your thoughts.